Screening of biochemical modulator by tumor cell permeability of doxorubicin

International Journal of Pharmaceutics

Volumn 354, Issue 1-2, 2008, Pages 63-69

  Sadzuka, Yasuyuki ^a,b   Hatakeyama, Haruna ^a   Daimon, Takashi ^a   Sonobe, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer chemotherapy; Cucurbitacin E; Doxorubicin; Efflux; Influx

Indexed keywords

CAPSAICIN; CAPSAICIN DERIVATIVE; CUCURBITACIN E; DOXORUBICIN; FERULIC ACID; GINGEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR VOLUME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CAPSAICIN; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; COUMARIC ACIDS; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FATTY ALCOHOLS; FEMALE; MALE; MICE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PERMEABILITY; SARCOMA; TRITERPENES;

EID: 40849083566     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.10.015     Document Type: Article

References (25)

1. Bertino R., Sawicki W.I., Lindquist C.A., and Gupta V.S. Schedule dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res. 37 (1977) 327-328
2. Bud G.T., Fleming R.M., Bukowski R.M., McCracken J.D., and Rinvkin S.E. 5-Fluorouracil and folinic acid in the treatment of advanced colorectal cancer, a randomized comparison. J. Clin. Oncol. 5 (1987) 272-277
3. Chen H.X., Bamberger U., Heckel A., Guo X., and Chen Y.C. BIBW 22, a dipyridamole analogue, acts as a biofunctional modulator on tumor cells by influencing both P-flycoprotein and nucleoside transport. Cancer Res. 53 (1993) 1974-1977
4. Hidalgo O.F., Gonzalez F., Gil A., Campbell W., Barrajon E., and Lacave A.J. 120 h simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer. Am. J. Clin. Oncol. 12 (1989) 397-401
5. Ichinose Y., Takahashi N., and Yano T. A phase III trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer. Cancer 75 (1995) 2677-2680
6. Jayaprakasam B., Seeram N.P., and Nair M.G. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Res. 189 (2003) 11-16
7. Kang Y., and Perry R.R. Effect of gamma-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. Cancer Res. 54 (1994) 2952-2958
8. Kawada T., Watanabe T., Takaishi T., Tanaka T., and Iwai K. Capsaicin-induced β-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc. Soc. Exp. Biol. Med. 183 (1986) 250-256
9. Kubota Y., Hosaka M., Fukushima S., and Kondo I. Prophylactic oral UFT therapy for superficial bladder cancer. Cancer 71 (1993) 1842-1845
10. O'Connel M.J. A phase III trial of 5-fluorouracil and leucovolin in the treatment of advanced colorectal cancer. Cancer 63 (1988) 1026-1030
11. Sadzuka Y., Mochizuki E., and Takino Y. Caffeine modulates the antitumor activity and toxic side effects of adriamycin. Jpn. J. Cancer Res. 84 (1993) 348-353
12. Sadzuka Y., Mochizuki E., Iwasaki A., Hirota S., and Takino Y. Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice. Biol. Pharm. Bull. 18 (1995) 159-161
13. Sadzuka Y., Mochizuki E., and Takino Y. Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol. Lett. 7 (1995) 39-49
14. Sadzuka Y., Sugiyama T., Miyagishima A., Nozawa Y., and Hirota S. The effects of theanine, as a novel biochemical modulator, on the antitumor activity adriamycin. Cancer Lett. 105 (1996) 203-209
15. Sadzuka Y., Sugiyama T., and Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol. Lett. 114 (2000) 155-162
16. Sadzuka Y., Sugiyama T., Tanaka K., and Sonobe T. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicol. Lett. 121 (2001) 89-96
17. Sadzuka Y., Sugiyama T., Suzuki, and Sonobe T. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett. 123 (2001) 159-167
18. Sazuka Y., Tanizawa H., and Takino Y. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catarase in tissues of mice. Jpn. J. Cancer Res. 80 (1989) 89-94
19. Sugiyama T., and Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett. 133 (1998) 19-26
20. Sugiyama T., and Sadzuka Y. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents. Biochim. Biophys. Acta 1653 (2003) 47-59
21. Sugiyama T., Sadzuka Y., and Sonobe T. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett. 212 (2004) 177-184
22. Surh Y.J., and Lee S.S. Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen?. Food Chem. Toxicol. 34 (1996) 313-316
23. Talmadge J.E., Key M.E., and Hart I.R. Characterization of murine ovarian Reticulum cell sarcoma of histiocytic origin. Cancer Res. 41 (1981) 1271-1280
24. Tsuchiya H. Biphasic membrane effects of capsaicin, an active component in capsicum species. J. Ethnopharmacol. 75 (2001) 295-299
25. Zou Y., Ling Y.H., Van N.T., Priebe W., and Perez-Soler R. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline with non-cross resistance properties. Cancer Res. 54 (1994) 1479-1484